Holen Sie sich die Stockscreener-App
94.78
0.08%
-0.08
Vorhandelsmarkt:
94.75
-0.03
-0.03%
Schlusskurs vom Vortag:
$94.86
Offen:
$94.82
24-Stunden-Volumen:
574.92K
Relative Volume:
0.28
Marktkapitalisierung:
$7.17B
Einnahmen:
$35.93M
Nettoeinkommen (Verlust:
$-244.56M
KGV:
-23.99
EPS:
-3.95
Netto-Cashflow:
$-157.31M
1W Leistung:
+0.19%
1M Leistung:
+0.52%
6M Leistung:
+114.48%
1J Leistung:
+88.43%
1-Tages-Spanne:
$94.75
$94.90
1-Wochen-Bereich:
$94.58
$95.30
52-Wochen-Spanne:
$33.19
$95.30
Merus N V Stock (MRUS) Company Profile
Firmenname
Merus N V
Sektor
Branche
Telefon
31 030 253 8800
Adresse
YALELAAN 62, 3584 CM UTRECHT
Vergleichen Sie MRUS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MRUS
Merus N V
|
94.78 | 7.19B | 35.93M | -244.56M | -157.31M | -3.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Merus N V Stock (MRUS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-17 | Eingeleitet | Barclays | Overweight |
| 2025-08-25 | Eingeleitet | Alliance Global Partners | Buy |
| 2025-02-13 | Eingeleitet | Piper Sandler | Overweight |
| 2025-02-07 | Eingeleitet | Wells Fargo | Overweight |
| 2024-11-21 | Eingeleitet | Goldman | Buy |
| 2024-10-24 | Eingeleitet | UBS | Buy |
| 2024-03-28 | Eingeleitet | Truist | Buy |
| 2024-03-04 | Bestätigt | Needham | Buy |
| 2023-11-02 | Eingeleitet | Canaccord Genuity | Buy |
| 2023-08-21 | Eingeleitet | TD Cowen | Outperform |
| 2022-08-02 | Eingeleitet | Stifel | Buy |
| 2022-02-11 | Eingeleitet | BMO Capital Markets | Outperform |
| 2022-02-10 | Eingeleitet | Needham | Buy |
| 2021-11-17 | Fortgesetzt | Guggenheim | Buy |
| 2021-06-07 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-04-08 | Eingeleitet | William Blair | Outperform |
| 2021-03-16 | Eingeleitet | SVB Leerink | Outperform |
| 2020-06-26 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-05-27 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2019-11-20 | Fortgesetzt | Guggenheim | Buy |
| 2019-06-28 | Eingeleitet | ROTH Capital | Buy |
| 2019-04-12 | Fortgesetzt | Guggenheim | Buy |
| 2019-04-03 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2019-03-27 | Eingeleitet | Berenberg | Buy |
| 2018-01-02 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2017-09-15 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2017-03-21 | Herabstufung | Citigroup | Buy → Neutral |
| 2016-12-22 | Hochstufung | Citigroup | Neutral → Buy |
| 2016-11-07 | Herabstufung | Citigroup | Buy → Neutral |
| 2016-06-13 | Eingeleitet | Citigroup | Buy |
| 2016-06-13 | Eingeleitet | Guggenheim | Buy |
| 2016-06-13 | Eingeleitet | Wedbush | Outperform |
Alle ansehen
Merus N V Aktie (MRUS) Neueste Nachrichten
Is Merus N.V. stock a buy for dividend growthJuly 2025 Rallies & Long-Term Investment Growth Plans - newser.com
Is Merus N.V. stock bottoming outWeekly Earnings Recap & Proven Capital Preservation Tips - newser.com
Will Merus N.V. stock outperform Nasdaq indexJuly 2025 Sector Moves & Safe Swing Trade Setups - newser.com
Will Merus N.V. (2GH) stock keep high P E multiplesJuly 2025 Decliners & High Conviction Buy Zone Picks - newser.com
Can Merus N.V. stock double in next 5 yearsQuarterly Performance Summary & Community Trade Idea Sharing Platform - newser.com
Is Merus N.V. stock reversal real or fakeJuly 2025 Outlook & Weekly Return Optimization Alerts - newser.com
Market reaction to Merus N.V.’s recent newsEarnings Miss & Advanced Swing Trade Entry Alerts - newser.com
Merus N.V. stock volume spike explained2025 Volatility Report & Community Shared Stock Ideas - newser.com
Can Merus N.V. (2GH) stock test all time highsMarket Movement Recap & Stepwise Trade Signal Implementation - newser.com
What market sentiment indicators show for Merus N.V. (2GH) stockWeekly Trade Report & Weekly Breakout Opportunity Watchlist - newser.com
Is Merus N.V. stock a buy before product launchesRecession Risk & Low Risk High Reward Ideas - newser.com
Will Merus N.V. stock deliver better than expected guidanceEarnings Risk Report & AI Powered Trade Plan Recommendations - newser.com
What risks investors should watch in Merus N.V. stockJuly 2025 Sentiment & Stock Portfolio Risk Management - newser.com
Key metrics from Merus N.V.’s quarterly data2025 Fundamental Recap & Accurate Entry/Exit Alerts - newser.com
Is Merus N.V. stock resilient to inflationJuly 2025 Catalysts & Smart Investment Allocation Insights - newser.com
Why Merus N.V. (2GH) stock could outperform next year2025 Short Interest & Reliable Momentum Entry Alerts - newser.com
Merus NV’s Financial Stability at Risk Due to Unproven ADClonics Technology and Supply Chain Vulnerabilities - TipRanks
Can Merus N.V. (2GH) stock sustain revenue momentumJuly 2025 Trade Ideas & Proven Capital Preservation Methods - newser.com
Merus NV Faces Uncertainty and Risks Amid Genmab A/S Transaction Delays - TipRanks
Merus (MRUS) Forecasts 58.4% Revenue Growth, Ongoing Losses Challenge Bullish Narratives - simplywall.st
Is Merus N.V. stock attractive for income investorsJuly 2025 Earnings & Trade Opportunity Analysis Reports - newser.com
Merus N.V. $MRUS Shares Sold by Moody Aldrich Partners LLC - MarketBeat
Will Merus N.V. stock sustain high P E ratiosWeekly Profit Analysis & Daily Chart Pattern Signal Reports - newser.com
Merus NV reports results for the quarter ended September 30Earnings Summary - TradingView
Merus stock maintains Market Perform rating at BMO Capital By Investing.com - Investing.com South Africa
Merus stock maintains Market Perform rating at BMO Capital - Investing.com
Genmab, Merus file US antitrust paperwork - MLex
Merus (NASDAQ:MRUS) Sets New 52-Week HighTime to Buy? - MarketBeat
Assessing Merus (MRUS) Valuation After This Year’s 120% Share Price Rally - simplywall.st
How big funds are accumulating Merus N.V. (2GH) stockDollar Strength & Growth Oriented Trade Recommendations - newser.com
Why Merus N.V. stock remains on buy listsWeekly Gains Report & Free Daily Entry Point Trade Alerts - newser.com
Why Merus N.V. stock appeals to dividend seekers2025 Volatility Report & Community Shared Stock Ideas - newser.com
Finanzdaten der Merus N V-Aktie (MRUS)
Umsatz
Nettogewinn
Free Cashflow
ENV
Merus N V-Aktie (MRUS) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Silverman Peter B. | COO & GC |
Jul 17 '25 |
Sale |
60.00 |
25,000 |
1,500,000 |
0 |
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):